The Effect of Production and Sales on Leverage and Profitability in The JKN Era (State-Owned and Private Pharmaceutical Companies Tbk, Period 2014–2018)

Pratista Hangline Herlistiana; MGS. Aritonang; Tedy Herdiana

doi:10.35877/454RI.daengku1921

Pratista Hangline Herlistiana Universitas Pancasila (ID)
MGS. Aritonang Universitas Pancasila, Indonesia (ID)
Tedy Herdiana Universitas Pancasila, Indonesia (ID)

https://doi.org/10.35877/454RI.daengku1921

Keywords: Production, Sales, Leverage, Profitability

Viewed = 0 time(s)

Abstract

The implementation of the National Health Insurance (JKN) by BPJS has an impact on the pharmaceutical industry, there are an increase in demand for generic drugs, resulting in increased production, increased drug consumption in quantity, but decreased sales because pharmaceutical companies have to compete with small margins. The purpose of this study is to describe the financial performance of pharmaceutical companies in the JKN era, to analyze the factors that can affect leverage and profitability. This research was conducted at state-owned pharmaceutical companies (PT. Kimia Farma and PT. Indofarma) and private pharmaceutical companies (PT Merck and PT Kalbe). The two independent variables in this study, namely production and sales, were analyzed to see how they affect the leverage and profitability dependent variables. Descriptive analysis shows the financial performance of each company in the JKN era. Product analysis shows that at PT Kimia Farma production has a strong correlation with leverage and sales growth has a strong correlation with profitability, at PT Indofarma production and sales growth has a strong correlation with leverage and profitability, at PT Merck leverage has a strong correlation with profitability, while the correlation between sales growth on leverage does not show a strong correlation with the four companies, at PT Kalbe sales growth has a strong influence on leverage and leverage has a strong effect on profitability

References

ARIFIN, N. U. R. FADHILAH. (n.d.). KEPUASAN KERJA TENAGA MEDIS PADA ERA JAMINAN KESEHATAN NASIONAL DI RUMAH SAKIT UMUM DAERAH SINJAI TAHUN 2017.

Handayany, Gemy Nastity. (2020). Kualitas Pelayanan Kefarmasian dan Kepuasan Pasien. Media Nusa Creative (MNC Publishing).

Indriasari, Erlita. (2017). Analisis Rasio Keuangan Sebagai Alat Ukur Kinerja Keuangan Industri Farmasi di Bursa Efek Indonesia (BEI).

JENIA, PERMATA. (2023). ANALISIS PERBANDINGAN KINERJA KEUANGAN PADA PERUSAHAAN FARMASI MILIK NEGARA (BUMN) DAN PERUSAHAAN FARMASI MILIK SWASTA (BUMS) DALAM PERSPEKTIF EKONOMI ISLAM (Studi Komparatif Pada Perusahaan Farmasi yang Terdaftar Di BEI Periode 2016-2020). UIN RADEN INTAN LAMPUNG.

MAKANAN, KEPALA BADAN PENGAWAS OBAT D. A. N. (2019). Peraturan Badan Pengawas Obat dan Makanan Nomor 25 Tahun 2019 Tentang Pedoman Cara Pembuatan Kosmetika yang Baik.

Martina, Yunita, & Hidayah, Nenden Restu. (2022). Analisis Rasio Profitabilitas Untuk Menilai Kinerja Keuangan Pada PT. Kimia Farma (PERSERO) Tbk. EKOMBIS REVIEW: Jurnal Ilmiah Ekonomi Dan Bisnis, 10(1), 67–75.

Raharni, Raharni, Supardi, Sudibyo, & Sari, Ida Diana. (2018). Kemandirian dan Ketersediaan Obat Era Jaminan Kesehatan Nasional (JKN): Kebijakan, Harga, dan Produksi Obat. Media Penelitian Dan Pengembangan Kesehatan, 28(4), 219–228.

RIDWAN, HENDRA. (2017). PERANCANGAN MODEL TIME-DRIVEN ACTIVITY-BASED COSTING PADA PERUSAHAAN FARMASI XYZ. UNIVERSITAS AIRLANGGA.

STOCK, PHARMACEUTICAL COMPANIES I. N. INDONESIAN. (n.d.). KEPUTUSAN KEUANGAN, EFISIENSI OPERASIONAL DAN INOVASI TERHADAP PENINGKATAN KINERJA KEUANGAN DAN NILAI PERUSAHAAN PADA PERUSAHAAN FARMASI DI BURSA EFEK INDONESIA THE FINANCIAL DECISION, OPERATIONAL EFFICIENCY.

Sugiyono, P. D. (2017). Metode penelitian bisnis: pendekatan kuantitatif, kualitatif, kombinasi, dan R&D. Penerbit CV. Alfabeta: Bandung, 225, 87.